Drug intelligence / Profile preview

Shenqi Yanshen Keli

Development stage
Unknown
Lead developer
Guangxi Zhongheng Chuangxin Pharmaceutical Research
Administration
Oral
01

Overview

Shenqi Yanshen Keli (参芪延肾颗粒) is a traditional Chinese medicine (TCM) formulation developed as an innovative Class 1.1 Chinese herbal drug. It is designed for the treatment of chronic glomerulonephritis, a type of chronic kidney disease. The product is an optimized hospital preparation with established human use experience and some clinical efficacy and safety data from preclinical pharmacological and toxicological studies. Its mechanism of action is based on TCM principles, primarily aiming to tonify Qi (vital energy), nourish the kidneys, and support overall renal function through multi-component herbal synergy. The specific active ingredients are not detailed in available sources but typically include herbs such as ginseng (Ren Shen), astragalus (Huang Qi), among others commonly used in similar formulations for kidney health[1].

Brand names
参芪延肾颗粒
Other names
参芪延肾颗粒Shenqi Yanshen Granules
02

Targets

JUN (Transcription factor Jun)MYC (MYC proto-oncogene protein)

Beyond the preview

Go deeper on Shenqi Yanshen Keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenqi Yanshen Keli.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call